Kumquat’s mission is to develop innovative therapies to bring about sustainable and life-changing benefits to cancer patients.
Employees: 11-50
Investors 2
| Date | Name | Website |
| - | OrbiMed | orbimed.co... |
| - | EcoR1 Capi... | ecor1cap.c... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 29.07.2021 | Eli Lilly hands Kumquat Biosciences $70M to kick off cancer ... | Eil Lilly is in the hunt for new immuno-oncology drugs and it’s paying Kumquat Biosciences $70 milli... | medcitynew... |
| - | Eli Lilly hands Kumquat Biosciences $70M to kick off cancer ... | Eil Lilly is in the hunt for new immuno-oncology drugs and it’s paying Kumquat Biosciences $70 milli... | medcitynew... |